Acidosis modifies effects of phosphorylated tropomyosin on the actin-myosin interaction in the myocardium

J Muscle Res Cell Motil. 2021 Jun;42(2):343-353. doi: 10.1007/s10974-020-09593-4. Epub 2021 Jan 3.

Abstract

Phosphorylation of α-tropomyosin (Tpm1.1), a predominant Tpm isoform in the myocardium, is one of the regulatory mechanisms of the heart contractility. The Tpm 1.1 molecule has one site of phosphorylation, Ser283. The degree of the Tpm phosphorylation decreases with age and also changes in heart pathologies. Myocardial pathologies, in particular ischemia, are usually accompanied by pH lowering in the cardiomyocyte cytosol. We studied the effects of acidosis on the structural and functional properties of the pseudo-phosphorylated form of Tpm1.1 with the S283D substitution. We found that in acidosis, the interaction of the N- and C-ends of the S283D Tpm molecules decreases, whereas that of WT Tpm does not change. The pH lowering increased thermostability of the complex of F-actin with S283D Tpm to a greater extent than with WT Tpm. Using an in vitro motility assay with NEM- modified myosin as a load, we assessed the effect of the Tpm pseudo-phosphorylation on the force of the actin-myosin interaction. In acidosis, the force generated by myosin in the interaction with thin filaments containing S283D Tpm was higher than with those containing WT Tpm. Also, the pseudo-phosphorylation increased the myosin ability to resist a load. We conclude that ischemia changes the effect of the phosphorylated Tpm on the contractile function of the myocardium.

Keywords: Calcium regulation; Cardiac myosin; In vitro motility assay; Tropomyosin; Tropomyosin phosphorylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acidosis*
  • Actins
  • Humans
  • Myocardium
  • Myosins
  • Tropomyosin*

Substances

  • Actins
  • Tropomyosin
  • Myosins